6-nitro-2-(((1-(4-chlorophenyl)-1H-1,2,3-triazol-4-yl)methyl)thio)-4H-benzo[e][1,3]thiazin-4-one

ID: ALA5205643

PubChem CID: 168296208

Max Phase: Preclinical

Molecular Formula: C17H10ClN5O3S2

Molecular Weight: 431.89

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=c1nc(SCc2cn(-c3ccc(Cl)cc3)nn2)sc2ccc([N+](=O)[O-])cc12

Standard InChI:  InChI=1S/C17H10ClN5O3S2/c18-10-1-3-12(4-2-10)22-8-11(20-21-22)9-27-17-19-16(24)14-7-13(23(25)26)5-6-15(14)28-17/h1-8H,9H2

Standard InChI Key:  ZXCJDHVCFAHSCS-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 28 31  0  0  0  0  0  0  0  0999 V2000
    2.2269   -1.0190    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.0474   -0.9328    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5322   -1.6003    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3526   -1.5140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6882   -0.7604    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5086   -0.6742    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    4.2032   -0.0930    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3828   -0.1792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6749   -0.4060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9213   -0.7415    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2069   -0.3291    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5074   -0.7415    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2219   -0.3291    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2219    0.4958    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9363    0.9083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9363    1.7332    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6508    0.4958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6508   -0.3291    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3652   -0.7415    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0796   -0.3291    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0796    0.4958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3652    0.9083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9363   -0.7415    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    1.0075   -1.5620    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.8144   -1.7335    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7941    0.9083    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7941    1.7335    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5086    0.4957    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  5  7  2  0
  8  2  2  0
  7  8  1  0
  9  1  1  0
  9 10  2  0
 11 10  1  0
 12 11  1  0
 13 12  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 17 15  1  0
 18 17  2  0
 19 18  1  0
 20 19  2  0
 21 20  1  0
 17 22  1  0
 22 21  2  0
 18 23  1  0
 23 13  1  0
 24 10  1  0
 25 24  2  0
  1 25  1  0
 21 26  1  0
 26 27  1  0
 26 28  2  0
M  CHG  2  26   1  27  -1
M  END

Alternative Forms

  1. Parent:

    ALA5205643

    ---

Associated Targets(non-human)

Mycobacteroides abscessus (2066 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mycolicibacterium fortuitum (1335 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mycobacteroides chelonae (540 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus aureus (210822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Escherichia coli (133304 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Klebsiella pneumoniae (43867 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pseudomonas aeruginosa (123386 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 431.89Molecular Weight (Monoisotopic): 430.9914AlogP: 4.09#Rotatable Bonds: 5
Polar Surface Area: 103.81Molecular Species: NEUTRALHBA: 9HBD:
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 4.60CX LogD: 4.60
Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.27Np Likeness Score: -2.57

References

1. Sahoo SK, Ahmad MN, Kaul G, Nanduri S, Dasgupta A, Chopra S, Yaddanapudi VM..  (2022)  Synthesis and evaluation of triazole congeners of nitro-benzothiazinones potentially active against drug resistant Mycobacterium tuberculosis demonstrating bactericidal efficacy.,  13  (5.0): [PMID:35694687] [10.1039/d1md00387a]

Source